Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rossouw, 2002, Writing Group for the Women’s Health Initiative: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321
Dahlman-Wright, 2006, International union of pharmacology. LXIV. Estrogen receptors, Pharmacol Rev, 58, 773, 10.1124/pr.58.4.8
Heldring, 2007, Estrogen receptors: how do they signal and what are their targets, Physiol Rev, 87, 905, 10.1152/physrev.00026.2006
Jordan, 2001, Selective estrogen receptor modulation: a personal perspective, Cancer Res, 61, 5683
Brzozowski, 1997, Molecular basis of agonism and antagonism in the oestrogen receptor, Nature, 389, 753, 10.1038/39645
Shiau, 2002, Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism, Nat Struct Biol, 9, 359
Anstead, 1997, The estradiol pharmacophore: ligand structure–estrogen receptor binding affinity relationships and a model for the receptor binding site, Steroids, 62, 268, 10.1016/S0039-128X(96)00242-5
Leitman, 2010, Regulation of specific target genes and biological responses by estrogen receptor subtype agonists, Curr Opin Pharmacol, 10, 629, 10.1016/j.coph.2010.09.009
Chang, 2006, Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells, Endocrinology, 147, 4831, 10.1210/en.2006-0563
Huang, 2014, Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer, Proc Natl Acad Sci USA, 111, 1933, 10.1073/pnas.1323719111
McPherson, 2010, Estrogen receptor-β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated, Proc Natl Acad Sci USA, 107, 3123, 10.1073/pnas.0905524107
Mak, 2010, ERβ impedes prostate cancer EMT by destabilizing HIF-1α and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading, Cancer Cell, 17, 319, 10.1016/j.ccr.2010.02.030
Pinton, 2010, Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib, PLoS ONE, 5, e14110, 10.1371/journal.pone.0014110
Yu, 2013, Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation, PLoS ONE, 8, e56667, 10.1371/journal.pone.0056667
Rudolph, 2012, Expression of oestrogen receptor β and prognosis of colorectal cancer, Br J Cancer, 107, 831, 10.1038/bjc.2012.323
Hartman, 2009, Tumor repressive functions of estrogen receptor β in SW480 colon cancer cells, Cancer Res, 69, 6100, 10.1158/0008-5472.CAN-09-0506
Weige, 2009, Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon, Cancer Res, 69, 9118, 10.1158/0008-5472.CAN-09-2348
Chakraborty, 2010, Lung cancer in women: role of estrogens, Expert Rev Respir Med, 4, 509, 10.1586/ers.10.50
Tang, 2013, Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice, Int J Cancer, 133, 2473, 10.1002/ijc.28262
Kawai, 2005, Estrogen receptor α and β are prognostic factors in non-small cell lung cancer, Clin Cancer Res, 11, 5084, 10.1158/1078-0432.CCR-05-0200
Schwartz, 2005, Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex, Clin Cancer Res, 11, 7280, 10.1158/1078-0432.CCR-05-0498
Hershberger, 2009, Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells, J Steroid Biochem Mol Biol, 116, 102, 10.1016/j.jsbmb.2009.05.004
Walf, 2010, Estradiol reduces anxiety- and depression-like behavior of aged female mice, Physiol Behav, 99, 169, 10.1016/j.physbeh.2009.09.017
Osterlund, 2010, Underlying mechanisms mediating the antidepressant effects of estrogens, Biochim Biophys Acta, 1800, 1136, 10.1016/j.bbagen.2009.11.001
Pike, 2009, Protective actions of sex steroid hormones in Alzheimer’s disease, Front Neuroendocrinol, 30, 239, 10.1016/j.yfrne.2009.04.015
Tiwari-Woodruff, 2007, Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)α and ERβ ligand treatment, Proc Natl Acad Sci USA, 104, 14813, 10.1073/pnas.0703783104
Thorp, 2009, Soya isoflavone supplementation enhances spatial working memory in men, Br J Nutr, 102, 1348, 10.1017/S0007114509990201
Vitale, 2009, Gender differences in the cardiovascular effect of sex hormones, Nat Rev Cardiol, 6, 532, 10.1038/nrcardio.2009.105
Murphy, 2011, Estrogen signaling and cardiovascular disease, Circ Res, 109, 687, 10.1161/CIRCRESAHA.110.236687
Guo, 2005, Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors α and β, J Biol Chem, 280, 19704, 10.1074/jbc.M501244200
Zhu, 2002, Abnormal vascular function and hypertension in mice deficient in estrogen receptor β, Science, 295, 505, 10.1126/science.1065250
Adlanmerini, 2014, Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions, Proc Natl Acad Sci USA, 111, E283, 10.1073/pnas.1322057111
Nilsson, 2011, Estrogen receptors: therapies targeted to receptor subtypes, Clin Pharmacol Ther, 89, 44, 10.1038/clpt.2010.226
Michael, 2001, Selective estrogen receptor modulators: the ideal estrogen replacement, Primary Care Update OB/Gyns, 8, 25, 10.1016/S1068-607X(00)00066-4
Harris, 2002, Characterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand, Endocrinology, 143, 4172, 10.1210/en.2002-220403
Recker, 2011, Long-term raloxifene for postmenopausal osteoporosis, Curr Med Res Opin, 27, 1755, 10.1185/03007995.2011.606312
Ropero, 2008, The role of estrogen receptors in the control of energy and glucose homeostasis, Steroids, 73, 874, 10.1016/j.steroids.2007.12.018
Ahmed, 2012, Effects of estrogen on hyperglycemia and liver dysfunction in diabetic male rats, Int J Physiol Pathophysiol Pharmacol, 4, 156
Mauvais-Jarvis, 2013, The role of estrogens in control of energy balance and glucose homeostasis, Endocr Rev, 34, 309, 10.1210/er.2012-1055
Stovall, 2009, MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women, Curr Opin Invest Drugs, 10, 365
Grady, 2009, MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial, Menopause, 16, 458, 10.1097/gme.0b013e31818e64dd
Jordan, 2003, Antiestrogens and selective estrogen receptor modulators as multi-functional medicines 1. Receptor interactions, J Med Chem, 46, 883, 10.1021/jm020449y
Jordan, 2003, Antiestrogens and selective estrogen receptor modulators as multi-functional medicines 2. Clinical considerations and new agents, J Med Chem, 46, 1081, 10.1021/jm020450x
Paterni, 2013, Estrogen receptor ligands: a patent review update, Expert Opin Ther Pat, 23, 1247, 10.1517/13543776.2013.805206
Nilsson, 2011, Development of subtype-selective oestrogen receptor-based therapeutics, Nat Rev Drug Disc, 10, 778, 10.1038/nrd3551
Schering AG. Preparation of 8β-hydroxycarbyl-substituted estratrienes for use as selective estrogens. WO2001077139 (2001).
Jenapharm G.m.b.H & Co., Preparation of 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols containing a 21,16α lactone ring with a preference for estrogen receptor alpha. WO2002026763 (2002).
Babiker, 2002, Estrogenic hormone actions in the heart: regulatory network and function, Cardiovasc Res, 53, 709, 10.1016/S0008-6363(01)00526-0
Sun, 2011, Attenuation of atherogenesis via the anti-inflammatory effects of the selective estrogen receptor beta modulator 8β-VE2, J Cardiovasc Pharmacol, 58, 399, 10.1097/FJC.0b013e318226bd16
Arias-Loza, 2012, The estrogen receptor-α is required and sufficient to maintain physiological glucose uptake in the mouse heart, Hypertension, 60, 1070, 10.1161/HYPERTENSIONAHA.111.190389
Velders, 2012, Selective estrogen receptor-β activation stimulates skeletal muscle growth and regeneration, FASEB J, 26, 1909, 10.1096/fj.11-194779
Yang, 2010, Endogenous estrogen regulation of inflammatory arthritis and cytokine expression in male mice, predominantly via estrogen receptor α, Arthritis Reum, 62, 1017, 10.1002/art.27330
Kuiper, 1998, The estrogen receptor β subtype: a novel mediator of estrogen action in neuroendocrine systems, Front Neuroendocrin, 19, 253, 10.1006/frne.1998.0170
Gold, 2009, Estrogen treatment in multiple sclerosis, J Neurol Sci, 286, 99, 10.1016/j.jns.2009.05.028
Saijo, 2011, An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation, Cell, 145, 584, 10.1016/j.cell.2011.03.050
Norata, 2010, The androgenderivative5α-androstane-3β,17β-diol inhibit stumor necrosis factor α and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta, Atherosclerosis, 212, 100, 10.1016/j.atherosclerosis.2010.05.015
Dondi, 2010, Estrogen receptor β and the progression of prostate cancer: role of 5α-androstane-3β,17β-diol, Endocr Relat Cancer, 17, 731, 10.1677/ERC-10-0032
Dey, 2014, Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer, Oncogene, 10.1038/onc.2013.384
Gibb, 1976, The specificity of the 3β-hydroxysteroid dehydrogenase activity of bovine ovaries toward dehydroepiandrosterone and pregnenolone: evidence for multiple enzymes, Steroids, 28, 31, 10.1016/0039-128X(76)90123-9
Melville, 2014, Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength, J Bone Miner Res, 29, 370, 10.1002/jbmr.2082
Neale, 2009, Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent, Bioorg Med Chem Lett, 19, 680, 10.1016/j.bmcl.2008.12.051
Zhao, 2009, 3D QSAR of novel estrogen–RGD peptide conjugates: getting insight into structural dependence of anti-osteoporosis activity and side effect of estrogen in ERT, Bioorg Med Chem, 17, 3680, 10.1016/j.bmc.2009.03.057
Zhao, 2009, Synthesis, evaluation and 3D QSAR analysis of novel estrogen–RGD octapeptide conjugates with oral anti-osteoporosis activity, Eur J Med Chem, 44, 1689, 10.1016/j.ejmech.2008.09.036
Zhao, 2013, Bone selective protective effect of a novel bone-seeking estrogen on trabecular bone in ovariectomized rats, Calcif Tissue Int, 93, 172, 10.1007/s00223-013-9739-1
Kim, 2006, Hormone-PAMAM dendrimer conjugates: polymer dynamics and tether structure affect ligand access to receptor, Angew Chem Int, 45, 7243, 10.1002/anie.200601923
Chambliss, 2010, Non-nuclear estrogen receptor α signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice, J Clin Invest, 120, 2320, 10.1172/JCI38291
McKie, 2004, Lead identification of a potent benzopyranone selective estrogen receptor modulator, Bioorg Med Chem Lett, 14, 3407, 10.1016/j.bmcl.2004.04.081
Signal Pharmaceuticals, Inc., Compounds and methods for modulation of estrogen receptors. US 6291456B1 (2000).
Hui, 2004, Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells, Cancer Res, 64, 9115, 10.1158/0008-5472.CAN-04-2740
http://www.clinicaltrials.gov (Accessed 25 February 2014).
Richardson, 2007, Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 3: Synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification, Bioorg Med Chem Lett, 17, 4824, 10.1016/j.bmcl.2007.06.052
Tan, 2012, Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand, Proc Natl Acad Sci USA, 109, 1708, 10.1073/pnas.1121162109
Suzuki, 2013, Involvement of estrogen receptor β in maintenance of serotonergic neurons of the dorsal raphe, Mol Psychiatry, 18, 674, 10.1038/mp.2012.62
Wu, 2013, Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis, Proc Natl Acad Sci USA, 110, 3543, 10.1073/pnas.1300313110
Saeed, 1990, Structure–activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans, J Med Chem, 33, 3210, 10.1021/jm00174a018
Sharma, 1990, Structure–activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans, J Med Chem, 33, 3216, 10.1021/jm00174a019
Sreenivasulu, 1993, Effect of a pure nonsteroidal antiestrogen, CDRI-85/287, on implantation-associated histological and biochemical changes in the rat uterus, Contraception, 48, 597, 10.1016/0010-7824(93)90121-M
Dwivedi, 1999, Endometrial steroid receptors during decidualization in rhesus monkey (Macaca mulatta); their modulation by anti-oestrogen CDRI-85/287, Hum Reprod, 14, 1090, 10.1093/humrep/14.4.1090
Saxena, 2013, Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft, Steroids, 78, 1071, 10.1016/j.steroids.2013.07.004
Hajela, 1999, Resolution, molecular structure and biological activities of the d- and l-enantiomers of potent anti-implantation agent, dl-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran, Bioorg Med Chem, 7, 2083, 10.1016/S0968-0896(99)00131-5
Saxena, 2013, Chemotherapeutic potential of 2-[piperidinoethoxyphenyl]-3-phenyl-2H-benzo(b)pyran in estrogen receptor-negative breast cancer cells: action via prevention of EGFR activation and combined inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 pathways, PLoS ONE, 8, e66246, 10.1371/journal.pone.0066246
Jain, 2009, Identification and structure–activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms, J Med Chem, 52, 7544, 10.1021/jm900146e
Jain, 2006, Novel chromene-derived selective estrogen receptor modulators useful for alleviating hot flushes and vaginal dryness, J Med Chem, 49, 3056, 10.1021/jm060353u
Piu, 2009, Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist, Eur J Pharmacol, 590, 423, 10.1016/j.ejphar.2008.05.015
Gardell, 2008, Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist, Eur J Pharmacol, 592, 158, 10.1016/j.ejphar.2008.06.107
George, 2013, Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer’s disease, ACS Chem Neurosci, 4, 1537, 10.1021/cn400133s
McFarland, 2013, AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson’s disease rat model, ACS Chem Neurosci, 4, 1249, 10.1021/cn400132u
Zhu, 2012, Synthesis and evaluation of fluoroethyl cyclofenil analogs: Models for potential estrogen receptor imaging agent, J Fluorine Chem, 139, 46, 10.1016/j.jfluchem.2012.04.005
Maruyama, 2013, Structure–activity relationships of bisphenol A analogs at estrogen receptors (ERs): Discovery of an ERα-selective antagonist, Bioorg Med Chem Lett, 23, 4031, 10.1016/j.bmcl.2013.05.067
Harris, 2003, Evaluation of an estrogen receptor-β agonist in animal models of human disease, Endocrinology, 144, 4241, 10.1210/en.2003-0550
Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis. Clinical Trial.gov. A service of the U.S. National Institutes of Health. Available at: www.clinicaltrials.gov/ct2/show/NCT00141830 (Last Accessed 28 February 2014).
Roman-Blas, 2010, Efficacy and safety of a selective estrogen receptor-β agonist, ERB-041, in patients with rheumatoid arthritis, Arthritis Care Res, 62, 1588, 10.1002/acr.20275
van Vollenhoven, 2010, The selective estrogen receptor α agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity, Arthritis Rheum, 62, 351, 10.1002/art.27196
Harris, 2005, A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis, Hum Reprod, 20, 936, 10.1093/humrep/deh711
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women. Clinical Trial.gov. A service of the U.S. National Institutes of Health. Available at: http://www.clinicaltrials.gov/ct2/show/study/NCT00318500 (Last Accessed 28 February 2014).
Guo, 2013, Lack of transparency of clinical trials on endometriosis, Obstet Gynecol, 121, 1281, 10.1097/AOG.0b013e318291f299
Chaudhary, 2013, Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway, Cancer Prev Res, 7, 186, 10.1158/1940-6207.CAPR-13-0276
Karo Bio AB. Novel Estrogen Receptor ligands. WO2009127686 (2009).
Yakimchuck, 2011, Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo, Leukemia, 25, 1103, 10.1038/leu.2011.68
Marzioni, 2012, An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma, Digest Liver Dis, 44, 134, 10.1016/j.dld.2011.06.014
Manente, 2013, Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo, Oncogenesis, 2, e72, 10.1038/oncsis.2013.32
De Angelis, 2005, Indazole estrogens: highly selective ligands for the estrogen receptor β, J Med Chem, 48, 1132, 10.1021/jm049223g
Meyers, 2001, Estrogen receptor beta potency-selective ligands: structure−activity relationship studies of diarylpropionitriles and their acetylene and polar analogues, J Med Chem, 44, 4230, 10.1021/jm010254a
Sun, 1999, Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor ralpha or estrogen receptor-beta, Endocrinology, 140, 800, 10.1210/endo.140.2.6480
Carroll, 2012, Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands, J Med Chem, 55, 528, 10.1021/jm201436k
Wilkening, 2006, The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands, Bioorg Med Chem Lett, 16, 3489, 10.1016/j.bmcl.2006.03.098
Clark, 2012, Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test, Neuropharmacology, 63, 1051, 10.1016/j.neuropharm.2012.07.004
Yepuru, 2010, Estrogen receptor-β selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice, J. Biol. Chem., 285, 31292, 10.1074/jbc.M110.147850
Pedram, 2013, Estrogen regulates histone deacetylases to prevent cardiac hypertrophy, Mol Biol Cell, 24, 3805, 10.1091/mbc.E13-08-0444
Giddabasappa, 2012, β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization, Invest Ophthalmol Vis Sci, 53, 5066, 10.1167/iovs.12-9627
Minutolo, 2003, Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta, Bioorg Med Chem, 11, 1247, 10.1016/S0968-0896(02)00640-5
Minutolo, 2009, Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor β, J Med Chem, 52, 858, 10.1021/jm801458t
Bertini, 2011, Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes, Eur J Med Chem, 46, 2453, 10.1016/j.ejmech.2011.03.030
Liao, 2014, Triaryl-substituted schiff bases are high-affinity subtype-selective ligands for the estrogen receptor, J Med Chem, 57, 3532, 10.1021/jm500268j
Ohta, 2014, Aliphatic substitution of o-carboranyl phenols enhances estrogen receptor beta selectivity, Chem Pharm Bull, 62, 386, 10.1248/cpb.c13-00796
Ohta, 2013, Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators, Bioorg Med Chem Lett, 23, 6555, 10.1016/j.bmcl.2013.10.067
Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta, Endocrinology, 138, 863, 10.1210/endo.138.3.4979
Velders, 2010, Estradiol and genistein antagonize the ovariectomy effects on skeletal muscle myosin heavy chain expression via ER-beta mediated pathways, J Steroid Biochem Mol Biol, 120, 53, 10.1016/j.jsbmb.2010.03.059
Bagheri, 2011, Genistein ameliorates learning and memory deficits in amyloid β(1–40) rat model of Alzheimer’s disease, Neurobiol Learn Mem, 95, 270, 10.1016/j.nlm.2010.12.001
Li, 2013, Brain endogenous estrogen levels determine responses to estrogen replacement therapy via regulation of BACE1 and NEP in female Alzheimer’s transgenic mice, Mol Neurobiol, 47, 857, 10.1007/s12035-012-8377-3
Pisani, 2012, Acute genistein treatment mimics the effects of estradiol by enhancing place learning and impairing response learning in young adult female rats, Horm Behav, 62, 491, 10.1016/j.yhbeh.2012.08.006
Donzelli, 2010, Neuroprotective effects of genistein in Mongolian gerbils: estrogen receptor-β involvement, J Pharmacol Sci, 114, 158, 10.1254/jphs.10164FP
Schleipen, 2011, ERβ-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine, Carcinogenesis, 32, 1675, 10.1093/carcin/bgr188
Slusarz, 2012, Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice, Endocrinology, 153, 4160, 10.1210/en.2012-1030
Nakamura, 2013, Genistein versus ICI 182, 780: an ally or enemy in metastatic progression of prostate cancer, Prostate, 73, 1747, 10.1002/pros.22712
Mahmoud, 2013, Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor, PLoS ONE, 8, e78479, 10.1371/journal.pone.0078479
Kim, 1998, Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways, Am J Clin Nutr, 68, 1418S, 10.1093/ajcn/68.6.1418S
Yu, 2012, Excess genistein suppresses the synthesis of extracellular matrix in female rat mandibular condylar cartilage, Acta Pharmacol Sin, 33, 918, 10.1038/aps.2012.49
Hayashi, 2013, The possibility of genistein as a new direct pulp capping agent, Dent Mater J, 32, 976, 10.4012/dmj.2013-091
Sullivan, 2011, Neonatal agonism of ERβ impairs male reproductive behavior and attractiveness, Horm Behav, 60, 185, 10.1016/j.yhbeh.2011.04.006
Gilbert, 2013, Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function, Food Funct, 4, 200, 10.1039/C2FO30199G
Weigt, 2013, Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female Wistar rats, Mol Cell Endocrinol, 377, 147, 10.1016/j.mce.2013.07.007
Pugalendhi, 2010, Chemopreventive potential of genistein and daidzein in combination during 7,12-dimethylbenz[a]anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats, Pak J Biol Sci, 13, 279, 10.3923/pjbs.2010.279.286
Zhao, 2009, A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo, Endocrinology, 150, 770, 10.1210/en.2008-0715
Zhao, 2011, Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause, Menopause, 18, 1131, 10.1097/gme.0b013e3182175b66
Zhao, 2013, Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer’s disease, J Alzheimer’s Dis, 37, 403, 10.3233/JAD-122341
Yao, 2013, Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments, Brain Res, 1514, 128, 10.1016/j.brainres.2013.02.021
Castro, 2012, Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats, Brain Res, 1474, 82, 10.1016/j.brainres.2012.07.025
Castro, 2014, Coumestrol treatment prevents Na+, K+-ATPase inhibition and affords histological neuroprotection to male rats receiving cerebral global ischemia, Neurol Res, 36, 198, 10.1179/1743132813Y.0000000286
Cvoro, 2007, Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract, Endocrinology, 148, 538, 10.1210/en.2006-0803
http://www.mf101.com/.
Bionovo Inc., Composition for treatment of menopause. US2006222721 (2006).
http://www.clinicaltrials.gov (Accessed 28 March 2014).
Sareddy, 2012, Therapeutic significance of estrogen receptor β agonists in gliomas, Mol Cancer Ther, 11, 1174, 10.1158/1535-7163.MCT-11-0960
Tolba, 2013, Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects, IUBMB Life, 65, 699, 10.1002/iub.1189
Jung, 2010, Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator, Phytother Res, 24, 295, 10.1002/ptr.2966
Bhargavan, 2012, Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: evidence for estrogen receptor β-mediated osteogenic action of medicarpin, J Nutr Biochem, 23, 27, 10.1016/j.jnutbio.2010.11.002
Tyagi, 2012, Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss, Osteoporos Int, 23, 1151, 10.1007/s00198-011-1650-x
Takemura, 2007, Characterization of the estrogenic activities of zearalenone and zeranol in vivo and in vitro, J Steroid Biochem Mol Biol, 103, 170, 10.1016/j.jsbmb.2006.08.008
Wang, 2010, Interaction of zearalenone and soybean isoflavone on the development of reproductive organs, reproductive hormones and estrogen receptor expression in prepubertal gilts, Anim Reprod Sci, 122, 317, 10.1016/j.anireprosci.2010.10.002
Seidlová-Wuttke, 2003, Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats, J Steroid Biochem Mol Biol, 86, 179, 10.1016/S0960-0760(03)00270-X
Barone, 2010, Dietary-induced ERβ upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice, Carcinogenesis, 31, 269, 10.1093/carcin/bgp275
Demirci, 2013, Silymarin improves vascular function of aged ovariectomized rats, Phytother Res, 28, 868, 10.1002/ptr.5067
El-Shitany, 2010, Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats, Phytomedicine, 17, 116, 10.1016/j.phymed.2009.05.012
Kim, 2013, Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis, BioMed Res Int, 10.1155/2013/919374
Baluchnejadmojarad, 2010, Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress, Neurosci Lett, 480, 206, 10.1016/j.neulet.2010.06.038
Suksamrarn, 2008, Diarylheptanoids, new phytoestrogens from the rhizomes of Curcuma comosa: isolation, chemical modification and estrogenic activity evaluation, Bioorg Med Chem, 16, 6891, 10.1016/j.bmc.2008.05.051
Winuthayanon, 2009, Estrogenic activity of diarylheptanoids from Curcuma comosa Roxb. Requires metabolic activation, J Agric Food Chem, 57, 840, 10.1021/jf802702c
Winuthayanon, 2009, Diarylheptanoid phytoestrogens isolated from the medicinal plant Curcuma comosa: biologic actions in vitro and in vivo indicate estrogen receptor-dependent mechanisms, Environ Health Perspect, 117, 1155, 10.1289/ehp.0900613
Winuthayanon, 2013, The natural estrogenic compound diarylheptanoid (D3): in vitro mechanisms of action and in vivo uterine responses via estrogen receptor α, Environ Health Perspect, 121, 433, 10.1289/ehp.1206122
Intapad, 2012, Long-term effect of phytoestrogens from Curcuma comosa Roxb. on vascular relaxation in ovariectomized rats, J Agric Food Chem, 60, 758, 10.1021/jf203173b
van Kruchten, 2013, PET imaging of oestrogen receptors in patients with breast cancer, Lancet Oncol, 14, e465, 10.1016/S1470-2045(13)70292-4
Yoo, 2005, Synthesis of an estrogen receptor β-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl) pentanenitrile and comparison of in vivo distribution with 16α-[18F]fluoro-17β-estradiol, J Med Chem, 48, 6366, 10.1021/jm050121f
Moon, 2008, Synthesis and evaluation of estrogen receptor β-selective ligands: Fluoroalkylated indazole estrogens, Bull Korean Chem Soc, 29, 1107, 10.5012/bkcs.2008.29.6.1107
Moon, 2009, Synthesis and evaluation of aryl-substituted diarylproprionitriles, selective ligands for estrogen receptor b, as positron-emission tomographic imaging agents, Bioorg Med Chem, 17, 3479, 10.1016/j.bmc.2009.02.064
Zhou, 2009, Bromination from the macroscopic level to the tracer radiochemical level: 76Br radiolabeling of aromatic compounds via electrophilic substitution, Bioconj Chem, 20, 808, 10.1021/bc800313c
Lee, 2012, Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance target, Nucl Med Biol, 39, 1105, 10.1016/j.nucmedbio.2012.05.011
Dehdashti, 2009, PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer, Breast Cancer Res Treat, 113, 509, 10.1007/s10549-008-9953-0
Fowler, 2012, Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer, J Nucl Med, 53, 1119, 10.2967/jnumed.112.103465